Medical-cannabis companies blast New York for ‘clear course for failure’ in state pot-business rollout

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 97%

Business News News

Business Business Latest News,Business Business Headlines

Curaleaf, Green Thumb Industries, PharmaCann and Acreage argue that a proliferation of illegal shops and dangerous products is harming the state.

New York state’s largest medical-cannabis companies, which have been barred from wading into the adult-use market for more than two years, are saying they’ve waited long enough for licenses from the state.

While cannabis was legalized in the state more than two years ago, existing medical-pot companies have not been issued any permits, because the state is issuing its first licenses to social-equity applicants under its Conditional Adult-Use Retail Dispensary Program . Such a move could add up to 33 retail cannabis locations to those currently operating in the state and, they said, “provide a dependable supply of safe, tested cannabis products.”

In July, the state’s Office of Cannabis Management approved 212 CAURD licenses, bringing the total number of licenses in the state to 463.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSİNESS

Business Business Latest News, Business Business Headlines